MiCONIV: Microbiologic Contamination of Home Non Invasive Ventilators

Sponsor
University Hospital, Rouen (Other)
Overall Status
Terminated
CT.gov ID
NCT03809832
Collaborator
ADIR Association (Other)
54
1
6.9
7.8

Study Details

Study Description

Brief Summary

Home non-invasive ventilators are daily used by patients with chronic respiratory failure. There are frequently used with warming and humidifying systems. These systems need to be cared for and frequently washed by the patient.

The aim of this study is to evaluate if the humidifying system of home ventilators are colonized by microbiological germs.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Microbiological sampling

Detailed Description

The use of non-invasive ventilators is common for treating respiratory failure. Their care relies on the patients and their carers.

No study has assessed the efficacy of such care with respect to the number of microbiological specimens that remain in the humidifier.

Study Design

Study Type:
Observational
Actual Enrollment :
54 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Microbiologic Contamination of Home Non Invasive Ventilators
Actual Study Start Date :
Jan 21, 2019
Actual Primary Completion Date :
Aug 20, 2019
Actual Study Completion Date :
Aug 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients with COPD

Patients established on home non-invasive ventilation for COPD admitted for respiratory review will have a microbiological sampling of the ventilator humidifier

Diagnostic Test: Microbiological sampling
An microbiological sampling of the ventilator humidifier will be performed.

Patients with OHS

Patients established on home non-invasive ventilation for obesity hypoventilation syndrome admitted for respiratory review will have a microbiological sampling of the ventilator humidifier

Diagnostic Test: Microbiological sampling
An microbiological sampling of the ventilator humidifier will be performed.

Outcome Measures

Primary Outcome Measures

  1. Prevalence of microbial contamination of non invasive ventilators humidifier [7 days]

Secondary Outcome Measures

  1. Microbiological ecology in the study population [7 days]

    The microbiological ecology of the ventilator humidifier will be describes (percentage of each pathogen)

  2. Comparison between COPD and Obesity hypoventilation syndrome patients microbial ecology [7 days]

    We will compare the microbiological ecology of patients in the COPD and in the Obesity hypoventilation group (percentage of each pathogen in each group)

  3. Compliance to recommendations regarding the maintenance of the humidifier [7 days]

    Compliance to recommendations will be assessed by a questionnaire containing 7 items regarding how the humidifier is maintained by the patient : Who is maintaining the ventilator (descriptive) At which frequency are you changing the water (Everyday (adequate), every other-day (almost adequate), every week (inadequate), more than weekly (inadequate) What type of water are you using (descriptive) At which frequency are you cleaning the mask (Everyday (adequate), every other-day (almost adequate), every week (inadequate), more than weekly (inadequate) At which frequency are you cleaning the humidifier (Everyday (adequate), every other-day (almost adequate), every week (inadequate), more than weekly (inadequate) How are you cleaning the humidifier? Water (inadequate), soap (adequate), dishawashing liquid (inadequate)

  4. Correlation between compliance to maintenance recommendations and contamination rate [7 days]

  5. Comparison of exacerbation frequency in COPD patients and isolation of respiratory pathogens in the humidifier [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient established on home non invasive ventilation for more than 6 months

  • With a compliance >4hours/day

  • Who brought their ventilator for the assessment

  • Diagnosed with COPD or Obesity hypoventilation syndrome (OHS)

  • Who consent

  • With an age > 18 years

Exclusion Criteria:
  • Age under 18

  • Ongoing exacerbation

  • Not able to consent

  • Pregnant or breastfeeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rouen University Hospital Bois-Guillaume Normandy France 76230

Sponsors and Collaborators

  • University Hospital, Rouen
  • ADIR Association

Investigators

  • Principal Investigator: Maxime Patout, MD, Rouen University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Rouen
ClinicalTrials.gov Identifier:
NCT03809832
Other Study ID Numbers:
  • 2018/363/OB
First Posted:
Jan 18, 2019
Last Update Posted:
Sep 4, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 4, 2019